共 27 条
- [6] Crystal structure of (1′R*,2R*,3R*,4S*,5S*,6S*)-2,3,4,5-tetrahydro-6-hydroxy-2-(1′-hydroxyethyl)-3-hydroxymethyl-5-methoxy-2,4-heptanofuran, C11H16O[CH(OH)CH3](OH)(CH2OH)(OCH3) ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 1998, 213 (02): : 295 - 296
- [7] PREPARATION AND STEREOCHEMISTRY OF COBALT(III) COMPLEXES CONTAINING 1,1,11,11-TETRAPHENYL-4,8-DIAZA-1,11-DIPHOSPHAUNDECANE OR (3S,9S)-3,9-DIMETHYL-1,1,11,11-TETRAPHENYL-4,8-DIAZA-1,11-DIPHOSPHAUNDECANE, (C6H5)2PCH2CHRNHCH2CH2CH2NHCHRCH2P(C6H5)2 (R=H OR CH3) BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN, 1988, 61 (10) : 3503 - 3509
- [8] Crystal structure of poly-[triaqua-(μ4-5′-carboxy-[1,1′-biphenyl]-2,3,3′-tricarboxylate-κ6O1,O2:O3, O4:O5:O6)praseodymium(III), C16H13O11Pr ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2017, 232 (01): : 3 - 5
- [9] Strikingly higher interleukin (IL)-1α, IL-1β and soluble interleukin-1 receptor antagonist (sIL-1RA) but similar IL-2, sIL-2R, IL-3, IL-4, IL-6, sIL-6R, IL-10, tumour necrosis factor (TNF)-α, transforming growth factor (TGF)-β2 and interferon IFN-γ urine levels in healthy females compared to healthy males:: protection against urinary tract injury? CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2005, 142 (02): : 312 - 317
- [10] CRYSTAL-STRUCTURE OF 1-1 COMPLEXES BETWEEN UREA AND 2 CROWN ETHER DERIVATIVES OF PHTHALIC-ACID, 2,3,5,6,8,9,11,12,14,15-DECAHYDROBENZO[1,4,7,10,13,16]HEXAOXACYCLOOCTADECIN-18,19-DICARBOXYLIC ACID (I) AND 2,3,5,6,8,9,11,12-OCTAHYDROBENZO[1,4,7,10,13]PENTAOXACYCLOPENTADECIN-15,16-DICARBOXYLIC ACID (II) JOURNAL OF HETEROCYCLIC CHEMISTRY, 1989, 26 (04) : 981 - 990